The company is holding an earnings conference call with analysts/investors as part of its investor engagement activities.
The event is scheduled for Thursday, November 12, 2026, at 04:00 PM IST.
The stated purpose is to discuss the company's financial performance for the Quarter and Half year ended September 30, 2026 (Q2 FY27).
The meeting is scheduled after the earnings announcement period as it will discuss completed financial results.
Management participants include:
Mr. Ram Agarwal, Chief Executive Officer and Whole Time Director
Mr. Abhishek Jain, Chief Financial Officer
The communication is made available on the company website at www.prostarm.com.
The disclosure is made pursuant to Regulation 30 and 46(2) of the SEBI Listing Regulations, indicating compliance with disclosure requirements.
Additional Notes Section
The document includes an earnings call invite attachment organized by Arihant Capital Markets Ltd.
No financial data or performance figures were disclosed in this announcement.
The call will be hosted by Arihant Capital Markets with universal dial-in numbers provided for India (+91 22 6280 1466, +91 22 7115 8826) and international toll-free numbers for Hong Kong (800964448), Singapore (8001012045), UK (08081011573), and USA (18667462133).
A DiamondPass registration link (https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6296051&linkSecurityString=384e45157e) is provided for express join without wait time.
Contact information for Arihant Capital Markets representatives is included: Abhishek Jain (Director-Institutional Research) and Rohan Baranwal (Research Analyst).
